Drug Type Gene editing |
Synonyms- |
Target |
Mechanism usherin modulators(Usherin modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization EdiGene Inc.Startup |
Active Organization EdiGene Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Usher Syndrome type 2 | Preclinical | CN | EdiGene Inc.Startup | 07 May 2024 |